[1]
S. Mishra, A. Ghosh, K. Sarker, A. Saha, S. Sen, “Identification, Biological Evaluation & Retrometabolic Drug Designing of Active Metabolites of 5-Amino-4-(3, 4-Dimethoxy Phenyl Sulfonamido)-5-Oxopentanoic Acid (SM-1) As Antimultiple Myeloma and Antiangiogenic Agents”, Annals of RSCB, pp. 458–469, May 2021.